Inhibitor Therapeutics, Inc (INTI) insider trading

Every open-market stock purchase and sale by Inhibitor Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Garrison J. Hasara (CFO), $945, 6 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent INTI insider trades

DateInsiderTradeValue
May 5, 2026Niraj Vasisht (Director)Bought (not open market)—
May 4, 2026Michael Allen Jerman (Director)Bought (not open market)—

Who's trading INTI

Get free alerts when an insider at Inhibitor Therapeutics, Inc files a new trade →